# Relevate Health

> Relevate Health combines healthcare marketing services, proprietary HCP data, medical games and EHR-based engagement for pharmaceutical, biotechnology and medical device brands. Its ELE Decision Engine supports targeting and campaign activation at the point of learning and point of clinical decision.

- **Founded:** 2007
- **Headquarters:** Blue Ash, United States
- **Founders:** Jeff Spanbauer (Co-founder; Chairman), Scott Weintraub (Co-founder; former President)
- **Products:** ELE Decision Engine, Point-of-Learning Solutions, Point-of-Clinical-Decision Solutions, Relevate Health Games, Level One
- **Notable:** Reports 185+ brand relationships and more than 600 annual campaigns., Built four add-on acquisitions during Mountaingate’s ownership., Games division reported ten new games in the first half of 2025.

## Products & services

- **ELE Decision Engine** — Proprietary intelligence supporting HCP segmentation, channel selection and activation using behavioral data and clinical signals.
- **Point-of-Learning Solutions** — Peer-to-peer content, expert programs, virtual meetings, interactive learning and targeted distribution.
- **Point-of-Clinical-Decision Solutions** — EHR-integrated clinical messaging, affordability resources and patient support connections.
- **Relevate Health Games** — Medical game development and deployment for HCP education; Level Ex pharma business acquired in 2024 and renamed in 2025.
- **Level One** — Interactive education for newly diagnosed Type 1 diabetes patients and caregivers.
- **Commercialization Services** — Brand strategy, creative, access planning, health-system engagement and campaign execution.
- **Flora Health formulary capability** — Co-developed delivery of context-specific coverage information inside EHR workflows.

## Achievements

- Reports 185+ brand relationships and more than 600 annual campaigns.
- Built four add-on acquisitions during Mountaingate’s ownership.
- Games division reported ten new games in the first half of 2025.
- PM360 named Jeff Spanbauer an ELITE Disrupter in 2022.

## Latest updates

- **2026-10** — Published an EHR campaign analysis reporting median TRx lift of 43.5% across 53 studies in 12 therapeutic areas; company-reported findings.
- **2026-09** — Appointed Oliver Nelson Chief Activation Officer.
- **2026-09** — Launched co-developed formulary capability with Flora Health.
- **2026-08** — Mountaingate announced its exit; industry reporting identified Linden as the buyer.
- **2025-08** — Level Ex pharma studio rebranded as Relevate Health Games.

## Links

- Website: https://www.relevatehealth.com/
- LinkedIn: https://www.linkedin.com/company/relevate-health/
- Twitter/X: https://twitter.com/Relevate
- Instagram: https://www.instagram.com/relevatehealth/
- Facebook: https://www.facebook.com/relevatehealth/

---

Profile page: https://yespress.io/relevate-health
Published by YesPress — https://yespress.io
Last updated: 2026-10-25